World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00353327
Date of registration: 17/07/2006
Primary sponsor: Hospital Clinic of Barcelona
Public title: Study of the Effectiveness of Passive Immunotherapy in HIV-Infected Patients Who Are in Virologic Failure
Scientific title: Passive Immunotherapy in HIV-Infected Patients Who Fail to Respond to Multiple Highly Active Antiretroviral Treatment. Randomized Study in Two Phases.
Date of first enrolment: October 2006
Target sample size: 30
Recruitment status: Suspended
URL:  http://clinicaltrials.gov/show/NCT00353327
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment  
Countries of recruitment
Spain
Contacts
Name:   Felipe Garcia, MD, PhD
Address: 
Telephone:
Email:
Affiliation:  Hospital ClĂ­nic Barcelona
Key inclusion & exclusion criteria

Inclusion Criteria:

- HIV-1 infected patients (CDC C category) confirmed by a Western-blot

- CD4 T cell count under 100/ml form 6 months before the inclusion, and who have never
been over 600 CD4 T cells/ml in the last 6 months, even if they have been receiving
HAART.

- The patients have received at least 3 different HAART regimens, and they have failed
to respond (define failure: CD4 T cell count under 100/ml and plasma viral load over
20,000 copies/ml).

- Plasma viral load over 20,000 copies/ml during at least 6 months.

- Written informed consent

- 18 years old or older

Exclusion Criteria:

- Asymptomatic patients who fill the A category of the CDC (1993)

- Younger than 18 years old

- Who are not expected to accomplish the treatment or the follow up visits

- Pregnancy, breast-feeding women, or women who want to get pregnant

- Denied consent



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
HIV Infection
Intervention(s)
Procedure: Plasma infusion
Primary Outcome(s)
Lowering of plasma viral load after a year
Lowering of plasma viral load after the first plasma infusion
Secondary Outcome(s)
Accomplishment
Dead
Development of C-events
Elevation of CD4 T cell count
HIV RNA mutations conferring resistance to HAART
Negativation of p24 HIV antigen
Toxicity
Secondary ID(s)
PIT-01
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history